These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28126630)

  • 21. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
    Gasiorek-Wiens A; Tercanli S; Kozlowski P; Kossakiewicz A; Minderer S; Meyberg H; Kamin G; Germer U; Bielicki M; Hackelöer BJ; Sarlay D; Kuhn P; Klapp J; Bahlmann F; Pruggmayer M; Schneider KT; Seefried W; Fritzer E; von Kaisenberg CS;
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of image magnification in first-trimester screening for Down syndrome by fetal nuchal translucency in Asians.
    Hsu JJ; Chiang CH; Hsieh CC; Hsieh TT
    Prenat Diagn; 2004 Dec; 24(12):1007-12. PubMed ID: 15614833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nuchal translucency: this is not so simple!].
    Constant M
    Gynecol Obstet Fertil; 2014 Dec; 42(12):820-1. PubMed ID: 25456489
    [No Abstract]   [Full Text] [Related]  

  • 28. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practitioner-specific medians for nuchal translucency to improve first-trimester screening performance.
    Wu N; Platt LD; Greene N; Currier RJ
    Obstet Gynecol; 2012 Apr; 119(4):785-94. PubMed ID: 22433342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A method for semi-automatic nuchal translucency thickness measurement.
    Pakdaman N; Arabalibeik H; Ghaffari SR; Tahmasbpour AR
    Stud Health Technol Inform; 2014; 196():307-11. PubMed ID: 24732528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of fetal nuchal translucency thickness by three-dimensional ultrasound.
    Paul C; Krampl E; Skentou C; Jurkovic D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Nov; 18(5):481-4. PubMed ID: 11844168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How imprecise may the measurement of fetal nuchal translucency be without worsening first-trimester screening?
    Schmidt P; Staboulidou I; Elsässer M; Vaske B; Hillemanns P; Scharf A
    Fetal Diagn Ther; 2008; 24(3):291-5. PubMed ID: 18818502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra- and interoperator reliability of manual and semi-automated measurement of fetal nuchal translucency by sonographers with different levels of experience.
    Abele H; Hoopmann M; Wright D; Hoffmann-Poell B; Huettelmaier M; Pintoffl K; Wallwiener D; Kagan KO
    Ultrasound Obstet Gynecol; 2010 Oct; 36(4):417-22. PubMed ID: 20734371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between nuchal translucency and nuchal skin-fold measurements in Down syndrome and unaffected fetuses.
    Maymon R; Zimerman AL; Weinraub Z; Herman A; Cuckle H
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):501-5. PubMed ID: 18512852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
    Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.